Viewing StudyNCT04540211



Ignite Creation Date: 2024-05-06 @ 3:11 PM
Last Modification Date: 2024-10-26 @ 1:44 PM
Study NCT ID: NCT04540211
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-05-13
First Post: 2020-09-03

Brief Title: A Study of Atezolizumab Plus Tiragolumab in Combination With Paclitaxel and Cisplatin Compared With Paclitaxel and Cisplatin as First-Line Treatment in Participants With Unresectable Locally Advanced Unresectable Recurrent or Metastatic Esophageal Carcinoma
Sponsor:
Organization: Hoffmann-La Roche